Our Vision
Myocardial Regeneration
The ultimate goal of clinical cardiology
Regencor's team envisions a future in which myocardial infarctions no longer impose incurable & life-threatening tissue damage or progression to heart failure
Regencor's THERAPEUTICS
Non-invasive subcutaneous delivery:
A true game-changer in heart disease therapy
Our recombinant protein REG101, delivered subcutaneously, reverses the formation of scar tissue. Scar tissue is the most serious complication of a myocardial infarction as it weakens the heart and leads to progressive heart failure.